Literature DB >> 19425168

Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats.

Kevin R Novak1, Paul Nardelli, Tim C Cope, Gregory Filatov, Jonathan D Glass, Jaffar Khan, Mark M Rich.   

Abstract

Neuropathy and myopathy can cause weakness during critical illness. To determine whether reduced excitability of peripheral nerves, rather than degeneration, is the mechanism underlying acute neuropathy in critically ill patients, we prospectively followed patients during the acute phase of critical illness and early recovery and assessed nerve conduction. During the period of early recovery from critical illness, patients recovered from neuropathy within days. This rapidly reversible neuropathy has not to our knowledge been previously described in critically ill patients and may be a novel type of neuropathy. In vivo intracellular recordings from dorsal root axons in septic rats revealed reduced action potential amplitude, demonstrating that reduced excitability of nerve was the mechanism underlying neuropathy. When action potentials were triggered by hyperpolarizing pulses, their amplitudes largely recovered, indicating that inactivation of sodium channels was an important contributor to reduced excitability. There was no depolarization of axon resting potential in septic rats, which ruled out a contribution of resting potential to the increased inactivation of sodium channels. Our data suggest that a hyperpolarized shift in the voltage dependence of sodium channel inactivation causes increased sodium inactivation and reduced excitability. Acquired sodium channelopathy may be the mechanism underlying acute neuropathy in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19425168      PMCID: PMC2673869          DOI: 10.1172/jci36570

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

1.  Altered gene expression in steroid-treated denervated muscle.

Authors:  M M Rich; S D Kraner; R L Barchi
Journal:  Neurobiol Dis       Date:  1999-12       Impact factor: 5.996

2.  Incidence and onset of critical illness polyneuropathy in patients with septic shock.

Authors:  M Tepper; S Rakic; J A Haas; A J Woittiez
Journal:  Neth J Med       Date:  2000-06       Impact factor: 1.422

3.  Critical illness myopathy.

Authors:  D Lacomis; D W Zochodne; S J Bird
Journal:  Muscle Nerve       Date:  2000-12       Impact factor: 3.217

4.  Sodium channel inactivation in an animal model of acute quadriplegic myopathy.

Authors:  M M Rich; M J Pinter
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

Review 5.  Neuromodulation of Na+ channels: an unexpected form of cellular plasticity.

Authors:  A R Cantrell; W A Catterall
Journal:  Nat Rev Neurosci       Date:  2001-06       Impact factor: 34.870

Review 6.  Critical illness polyneuropathy, facts and controversies.

Authors:  F S Leijten; A W de Weerd
Journal:  J Peripher Nerv Syst       Date:  1996       Impact factor: 3.494

7.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 8.  Resurgence of sodium channel research.

Authors:  A L Goldin
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

9.  Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis.

Authors:  A Tennilä; T Salmi; V Pettilä; R O Roine; T Varpula; O Takkunen
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

Review 10.  Mechanisms of neuromuscular dysfunction in critical illness.

Authors:  Jaffar Khan; Taylor B Harrison; Mark M Rich
Journal:  Crit Care Clin       Date:  2008-01       Impact factor: 3.598

View more
  35 in total

1.  A novel path to chronic proprioceptive disability with oxaliplatin: Distortion of sensory encoding.

Authors:  Jacob A Vincent; Krystyna B Wieczerzak; Hanna M Gabriel; Paul Nardelli; Mark M Rich; Timothy C Cope
Journal:  Neurobiol Dis       Date:  2016-07-07       Impact factor: 5.996

Review 2.  Intensive care unit-acquired weakness: implications for physical therapist management.

Authors:  Amy Nordon-Craft; Marc Moss; Dianna Quan; Margaret Schenkman
Journal:  Phys Ther       Date:  2012-01-26

Review 3.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

4.  Review of Critical Illness Myopathy and Neuropathy.

Authors:  Starane Shepherd; Ayush Batra; David P Lerner
Journal:  Neurohospitalist       Date:  2016-08-23

5.  Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness: an observational cohort study.

Authors:  Luuk Wieske; Camiel Verhamme; Esther Witteveen; Aline Bouwes; Daniela S Dettling-Ihnenfeldt; Marike van der Schaaf; Marcus J Schultz; Ivo N van Schaik; Janneke Horn
Journal:  Neurocrit Care       Date:  2015-06       Impact factor: 3.210

6.  Alterations of action potentials and the localization of Nav1.6 sodium channels in spared axons after hemisection injury of the spinal cord in adult rats.

Authors:  Arsen S Hunanyan; Valentina Alessi; Samik Patel; Damien D Pearse; Gary Matthews; Victor L Arvanian
Journal:  J Neurophysiol       Date:  2010-12-22       Impact factor: 2.714

Review 7.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

8.  MitoTEMPOL, a mitochondrial targeted antioxidant, prevents sepsis-induced diaphragm dysfunction.

Authors:  Gerald S Supinski; Lin Wang; Elizabeth A Schroder; Leigh Ann P Callahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-27       Impact factor: 5.464

9.  Peripheral nerve conduction abnormalities precede morphological alterations in an experimental rat model of sepsis.

Authors:  Arisa Miura; Hirofumi Hino; Kazuhide Uchida; Soichiro Inoue; Takeshi Tateda
Journal:  J Anesth       Date:  2016-09-09       Impact factor: 2.078

Review 10.  [Critical illness polyneuropathy and critical illness myopathy].

Authors:  A Grimm; A Günther; O W Witte; H Axer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-10-28       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.